ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pneumococcal Conjugate Vaccine (PCV) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7X5985
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pneumococcal Conjugate Vaccine PCV Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Pneumococcal Conjugate Vaccine (PCV) Market Research Report 2025

Code: QYRE-Auto-7X5985
Report
July 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Serum Institute of India

Pneumococcal Conjugate Vaccine (PCV) Market Size

The global market for Pneumococcal Conjugate Vaccine (PCV) was valued at US$ 4380 million in the year 2024 and is projected to reach a revised size of US$ 5443 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Pneumococcal Conjugate Vaccine (PCV) Market

Pneumococcal Conjugate Vaccine (PCV) Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Conjugate Vaccine (PCV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Conjugate Vaccine (PCV).
The Pneumococcal Conjugate Vaccine (PCV) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Conjugate Vaccine (PCV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Conjugate Vaccine (PCV) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pneumococcal Conjugate Vaccine (PCV) Market Report

Report Metric Details
Report Name Pneumococcal Conjugate Vaccine (PCV) Market
Accounted market size in year US$ 4380 million
Forecasted market size in 2031 US$ 5443 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 23-valent Vaccine
  • 10-valent Vaccine
  • 7-valent Vaccine
  • 13-valent Vaccine
Segment by Application
  • Child
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biologic, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pneumococcal Conjugate Vaccine (PCV) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pneumococcal Conjugate Vaccine (PCV) Market growing?

Ans: The Pneumococcal Conjugate Vaccine (PCV) Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Pneumococcal Conjugate Vaccine (PCV) Market size in 2031?

Ans: The Pneumococcal Conjugate Vaccine (PCV) Market size in 2031 will be US$ 5443 million.

Who are the main players in the Pneumococcal Conjugate Vaccine (PCV) Market report?

Ans: The main players in the Pneumococcal Conjugate Vaccine (PCV) Market are Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biologic, Serum Institute of India

What are the Application segmentation covered in the Pneumococcal Conjugate Vaccine (PCV) Market report?

Ans: The Applications covered in the Pneumococcal Conjugate Vaccine (PCV) Market report are Child, Adult

What are the Type segmentation covered in the Pneumococcal Conjugate Vaccine (PCV) Market report?

Ans: The Types covered in the Pneumococcal Conjugate Vaccine (PCV) Market report are 23-valent Vaccine, 10-valent Vaccine, 7-valent Vaccine, 13-valent Vaccine

Recommended Reports

Human Vaccine Markets

Vaccine Delivery & Devices

Pediatric & Preventable Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 23-valent Vaccine
1.2.3 10-valent Vaccine
1.2.4 7-valent Vaccine
1.2.5 13-valent Vaccine
1.3 Market by Application
1.3.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Perspective (2020-2031)
2.2 Global Pneumococcal Conjugate Vaccine (PCV) Growth Trends by Region
2.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Region (2020-2025)
2.2.3 Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Region (2026-2031)
2.3 Pneumococcal Conjugate Vaccine (PCV) Market Dynamics
2.3.1 Pneumococcal Conjugate Vaccine (PCV) Industry Trends
2.3.2 Pneumococcal Conjugate Vaccine (PCV) Market Drivers
2.3.3 Pneumococcal Conjugate Vaccine (PCV) Market Challenges
2.3.4 Pneumococcal Conjugate Vaccine (PCV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue
3.1.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue (2020-2025)
3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Players (2020-2025)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pneumococcal Conjugate Vaccine (PCV) Revenue
3.4 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio
3.4.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2024
3.5 Global Key Players of Pneumococcal Conjugate Vaccine (PCV) Head office and Area Served
3.6 Global Key Players of Pneumococcal Conjugate Vaccine (PCV), Product and Application
3.7 Global Key Players of Pneumococcal Conjugate Vaccine (PCV), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Type
4.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Type (2020-2025)
4.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2026-2031)
5 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Application
5.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Application (2020-2025)
5.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size (2020-2031)
6.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025)
6.4 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size (2020-2031)
7.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025)
7.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size (2020-2031)
8.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2020-2025)
8.4 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size (2020-2031)
9.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025)
9.4 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size (2020-2031)
10.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025)
10.4 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Introduction
11.1.4 Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Introduction
11.2.4 GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Introduction
11.3.4 Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Introduction
11.4.4 Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Company Details
11.5.2 Walvax Biotechnology Business Overview
11.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Introduction
11.5.4 Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.5.5 Walvax Biotechnology Recent Development
11.6 Royal (Wuxi) Bio-Pharmaceutical
11.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Details
11.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
11.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Introduction
11.6.4 Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
11.7 Zhifei Biologic
11.7.1 Zhifei Biologic Company Details
11.7.2 Zhifei Biologic Business Overview
11.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Introduction
11.7.4 Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.7.5 Zhifei Biologic Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Introduction
11.8.4 Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
11.8.5 Serum Institute of India Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Serum Institute of India
List of Tables
 Table 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 23-valent Vaccine
 Table 3. Key Players of 10-valent Vaccine
 Table 4. Key Players of 7-valent Vaccine
 Table 5. Key Players of 13-valent Vaccine
 Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2020-2025)
 Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2026-2031)
 Table 12. Pneumococcal Conjugate Vaccine (PCV) Market Trends
 Table 13. Pneumococcal Conjugate Vaccine (PCV) Market Drivers
 Table 14. Pneumococcal Conjugate Vaccine (PCV) Market Challenges
 Table 15. Pneumococcal Conjugate Vaccine (PCV) Market Restraints
 Table 16. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players (2020-2025)
 Table 18. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2024)
 Table 19. Ranking of Global Top Pneumococcal Conjugate Vaccine (PCV) Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Pneumococcal Conjugate Vaccine (PCV), Headquarters and Area Served
 Table 22. Global Key Players of Pneumococcal Conjugate Vaccine (PCV), Product and Application
 Table 23. Global Key Players of Pneumococcal Conjugate Vaccine (PCV), Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2020-2025)
 Table 27. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2026-2031)
 Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2020-2025)
 Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2026-2031)
 Table 33. North America Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Pfizer Company Details
 Table 49. Pfizer Business Overview
 Table 50. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product
 Table 51. Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 52. Pfizer Recent Development
 Table 53. GSK Company Details
 Table 54. GSK Business Overview
 Table 55. GSK Pneumococcal Conjugate Vaccine (PCV) Product
 Table 56. GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 57. GSK Recent Development
 Table 58. Sanofi Company Details
 Table 59. Sanofi Business Overview
 Table 60. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product
 Table 61. Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 62. Sanofi Recent Development
 Table 63. Merck Company Details
 Table 64. Merck Business Overview
 Table 65. Merck Pneumococcal Conjugate Vaccine (PCV) Product
 Table 66. Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 67. Merck Recent Development
 Table 68. Walvax Biotechnology Company Details
 Table 69. Walvax Biotechnology Business Overview
 Table 70. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product
 Table 71. Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 72. Walvax Biotechnology Recent Development
 Table 73. Royal (Wuxi) Bio-Pharmaceutical Company Details
 Table 74. Royal (Wuxi) Bio-Pharmaceutical Business Overview
 Table 75. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product
 Table 76. Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 77. Royal (Wuxi) Bio-Pharmaceutical Recent Development
 Table 78. Zhifei Biologic Company Details
 Table 79. Zhifei Biologic Business Overview
 Table 80. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product
 Table 81. Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 82. Zhifei Biologic Recent Development
 Table 83. Serum Institute of India Company Details
 Table 84. Serum Institute of India Business Overview
 Table 85. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product
 Table 86. Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025) & (US$ Million)
 Table 87. Serum Institute of India Recent Development
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Pneumococcal Conjugate Vaccine (PCV) Picture
 Figure 2. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type: 2024 VS 2031
 Figure 4. 23-valent Vaccine Features
 Figure 5. 10-valent Vaccine Features
 Figure 6. 7-valent Vaccine Features
 Figure 7. 13-valent Vaccine Features
 Figure 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2024 VS 2031
 Figure 10. Child Case Studies
 Figure 11. Adult Case Studies
 Figure 12. Pneumococcal Conjugate Vaccine (PCV) Report Years Considered
 Figure 13. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pneumococcal Conjugate Vaccine (PCV) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Region: 2024 VS 2031
 Figure 16. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players in 2024
 Figure 17. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2024
 Figure 19. North America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2020-2031)
 Figure 21. United States Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2020-2031)
 Figure 25. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2020-2031)
 Figure 33. China Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2020-2031)
 Figure 41. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2020-2031)
 Figure 45. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 49. GSK Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 50. Sanofi Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 51. Merck Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 52. Walvax Biotechnology Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 53. Royal (Wuxi) Bio-Pharmaceutical Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 54. Zhifei Biologic Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 55. Serum Institute of India Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
13 Valent Pneumococcal Polysaccharide Conjugate Vaccine PCV13 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Paediatric Vaccine Market
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025
Global GP Vaccination Market Research Report 2025
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IPV Vaccine Market Research Report 2025
Vaccine Glass Vials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Global Attenuated Vaccine Market Research Report 2025
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Packaging Container Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions